McDermott Will & Schulte has advised ADAR1 Capital Management. Cooley has advised Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced a major capital...
Keros Therapeutics Announces $375 Million Capital Return Program with Share Repurchases and Tender Offer
LB Pharmaceuticals Launches $285 Million Initial Public Offering
Cooley has advised LB Pharmaceuticals on the offering, and Mintz has advised the underwriters. LB Pharmaceuticals Inc has announced the pricing of its upsized initial public...
Build Acquisition’s $200 Million Initial Public Offering
Shearman & Sterling advised Build Acquisition Corp. on the deal. Build Acquisition Corp., a special-purpose acquisition company, executed its initial public offering of 20 million units at...
Waldencast Acquisition’s $345 Million Initial Public Offering
Shearman & Sterling advised Credit Suisse and J.P. Morgan as joint book-running managers on the IPO. Waldencast Acquisition Corp., a special-purpose acquisition company, executed its initial...